An immunohistochemical study of p16INK4a expression in multistep thyroid tumourigenesis

Lukas, 1995, Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16, Nature, 375, 503, 10.1038/375503a0 Koh, 1995, Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition, Nature, 375, 506, 10.1038/375506a0 Nobori, 1994, Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers, Nature, 368, 753, 10.1038/368753a0 Okamoto, 1994, Mutations and altered expression of p16INK4 in human cancer, Proc Natl Acad Sci USA, 91, 11045, 10.1073/pnas.91.23.11045 Hirama, 1995, Role of the cyclin-dependent kinase inhibitors in the development of cancer, Blood, 86, 841, 10.1182/blood.V86.3.841.841 Sherr, 1996, Cancer cell cycles, Science, 274, 1672, 10.1126/science.274.5293.1672 Baylin, 1998, Alterations in DNA methylation: a fundamental aspect of neoplasia, Adv Cancer Res, 72, 141, 10.1016/S0065-230X(08)60702-2 Jones, 2000, Evidence for a telomere-independent “clock” limiting RAS oncogene-driven proliferation of human thyroid epithelial cells, Mol Cell Biol, 20, 5690, 10.1128/MCB.20.15.5690-5699.2000 Bond, 2004, Direct evidence from siRNA-directed ‘knock down’ that p16(INK4a) is required for human fibroblast senescence and for limiting ras-induced epithelial cell proliferation, Exp Cell Res, 292, 151, 10.1016/j.yexcr.2003.09.021 Jones, 1996, High frequency deletion of the tumour suppressor gene P16INK4a (MTS1) in human thyroid cancer cell lines, Mol Cell Endocrinol, 116, 115, 10.1016/0303-7207(95)03697-0 Lemoine, 1989, Characterisation of human thyroid epithelial cells immortalised in vitro by simian virus 40 DNA transfection, Br J Cancer, 60, 897, 10.1038/bjc.1989.387 Wyllie, 1995, Evasion of p53-mediated growth control occurs by three alternative mechanisms in transformed thyroid epithelial cells, Oncogene, 10, 49 Morgan, 2001, A protocol for preparing cell suspensions with formalin fixation and paraffin embedding which minimises the formation of cell aggregates, J Cell Pathol, 5, 171 Sabattini, 1998, The EnVision++ system: a new immunohistochemical method for diagnostics and research. Critical comparison with the APAAP, ChemMate, CSA, LABC, and SABC techniques, J Clin Pathol, 51, 506, 10.1136/jcp.51.7.506 Murphy, 2003, p16INK4a as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep™ smears, J Clin Pathol, 56, 56, 10.1136/jcp.56.1.56 Misell, 2005, Development of a novel method for measuring in vivo breast epithelial cell proliferation in humans, Breast Cancer Res Treat, 89, 257, 10.1007/s10549-004-2228-5 Mengel, 2002, Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial, J Pathol, 198, 292, 10.1002/path.1218 Freeman, 1999, Minichromosome maintenance proteins as biological markers of dysplasia and malignancy, Clin Cancer Res, 5, 2121 Wharton, 2001, Replicative Mcm2 protein as a novel proliferation marker in oligodendrogliomas and its relationship to Ki67 labelling index, histological grade and prognosis, Neuropathol Appl Neurobiol, 27, 305, 10.1046/j.0305-1846.2001.00333.x Bukholm, 2001, Over-expression of cyclin A is highly associated with early relapse and reduced survival in patients with primary breast carcinomas, Int J Cancer, 93, 283, 10.1002/ijc.1311 Dutta, 1995, Cyclins as markers of tumor proliferation: immunocytochemical studies in breast cancer, Proc Natl Acad Sci USA, 92, 5386, 10.1073/pnas.92.12.5386 Pagano, 1992, Cyclin A is required at two points in the human cell cycle, Embo J, 11, 961, 10.1002/j.1460-2075.1992.tb05135.x Yane, 1996, Lack of p16/CDKN2 alterations in thyroid carcinomas, Cancer Lett, 101, 85, 10.1016/0304-3835(96)04117-1 Calabro, 1996, Status and expression of the p16INK4 gene in human thyroid tumors and thyroid-tumor cell lines, Int J Cancer, 67, 29, 10.1002/(SICI)1097-0215(19960703)67:1<29::AID-IJC7>3.0.CO;2-1 Elisei, 1998, Genetic and epigenetic alterations of the cyclin-dependent kinase inhibitors p15INK4b and p16INK4a in human thyroid carcinoma cell lines and primary thyroid carcinomas, Cancer, 83, 2185, 10.1002/(SICI)1097-0142(19981115)83:10<2185::AID-CNCR18>3.0.CO;2-4 Tung, 1996, Infrequent CDKN2 mutation in human differentiated thyroid cancers, Mol Carcinog, 15, 5, 10.1002/(SICI)1098-2744(199601)15:1<5::AID-MC2>3.0.CO;2-K Ferenc, 2004, Analysis of P161NK4A protein expression in follicular thyroid tumors, Pol J Pathol, 55, 143 Yoshida, 1999, Apoptosis and proliferative activity in thyroid tumors, Surg Today, 29, 204, 10.1007/BF02483007 Stoeber, 2001, DNA replication licensing and human cell proliferation, J Cell Sci, 114, 2027, 10.1242/jcs.114.11.2027 Palmqvist, 2000, Human colorectal cancers with an intact p16/Cyclin D1/pRb pathway have upregulated p16 expression and decreased proliferation in small invasive tumour clusters, Am J Pathol, 157, 1947, 10.1016/S0002-9440(10)64833-X Dai, 2000, P16INK4a expression begins early in human colon neoplasia and correlates inversely with markers of cell proliferation, Gastroenterology, 119, 929, 10.1053/gast.2000.17952 Zhao, 2003, Expressing patterns of p16 and CDK4 correlated to prognosis in colorectal carcinoma, World J Gastroenterol, 9, 2202, 10.3748/wjg.v9.i10.2202 Reed, 1995, Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression, Cancer Res, 55, 2713 Polsky, 2001, The transcriptional repressor of p16/Ink4a, Id1, is up-regulated in early melanomas, Cancer Res, 61, 6008 Straume, 2000, Loss of nuclear p16 protein expression correlates with increased tumor cell proliferation (Ki-67) and poor prognosis in patients with vertical growth phase melanoma, Clin Cancer Res, 6, 1845 Alonso, 2004, Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study, Am J Pathol, 164, 193, 10.1016/S0002-9440(10)63110-0 Skinner, 2004, Opposing effects of mutant ras oncoprotein on human fibroblast and epithelial cell proliferation: implications for models of human tumorigenesis, Oncogene, 23, 5994, 10.1038/sj.onc.1207798